Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Efficacy does not necessarily translate to cost effectiveness: a case study in the challenges associated with 21st-century cancer drug pricing.

× No keyword cloud information.

31 in total

1. Finasteride and prostate cancer: a commentary.

Authors: Channing J Paller; Thomas J Smith
Journal: Oncologist Date: 2012-06-20

Review 2. Advances in cancer therapeutics and patient access to new drugs.

Authors: George Dranitsaris; Ilse Truter; Martie S Lubbe; Eitan Amir; William Evans
Journal: Pharmacoeconomics Date: 2011-03 Impact factor: 4.981

3. Posaconazole versus fluconazole or itraconazole for prevention of invasive fungal infections in patients undergoing intensive cytotoxic therapy for acute myeloid leukemia or myelodysplasia: a cost effectiveness analysis.

Authors: George Dranitsaris; Haytham Khoury
Journal: Support Care Cancer Date: 2010-10-23 Impact factor: 3.603

4. Using pharmacoeconomic modelling to determine value-based pricing for new pharmaceuticals in malaysia.

Authors: George Dranitsaris; Ilse Truter; Martie S Lubbe; Nitin N Sriramanakoppa; Vivian M Mendonca; Sangameshwar B Mahagaonkar
Journal: Malays J Med Sci Date: 2011-10

5. Cutting the cost of cancer care.

Authors: Helmy M Guirgis
Journal: Gastrointest Cancer Res Date: 2009-07

6. Cancer care burden: aiming at the Achilles heel.

Authors: S Ahmed; R K Shahid; K Gesy
Journal: Curr Oncol Date: 2015-06 Impact factor: 3.677

7. Cancer drugs in the United States: Justum Pretium--the just price.

Authors: Hagop M Kantarjian; Tito Fojo; Michael Mathisen; Leonard A Zwelling
Journal: J Clin Oncol Date: 2013-05-06 Impact factor: 44.544

8. Cost-Savings Analysis of AR-V7 Testing in Patients With Metastatic Castration-Resistant Prostate Cancer Eligible for Treatment With Abiraterone or Enzalutamide.

Authors: Mark C Markowski; Kevin D Frick; James R Eshleman; Jun Luo; Emmanuel S Antonarakis
Journal: Prostate Date: 2016-07-12 Impact factor: 4.104

9. Bending the cost curve in cancer care.

Authors: Thomas J Smith; Bruce E Hillner
Journal: N Engl J Med Date: 2011-05-26 Impact factor: 91.245

10. Correlation between progression-free survival and overall survival in metastatic breast cancer patients receiving anthracyclines, taxanes, or targeted therapies: a trial-level meta-analysis.

Authors: George Adunlin; John W W Cyrus; George Dranitsaris
Journal: Breast Cancer Res Treat Date: 2015-11-23 Impact factor: 4.872